Skip to main content

Advertisement

Table 5 Prevalence of HPV by head and neck cancer type a

From: Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis

Cancer type Number of patients/patient samples tested Prevalence (%) 95% confidence interval
Low (%) High (%)
Base of tongue 193 47.2 37.3 57.1
Hypopharyngeal 50 42.4 14.7 70.2
Laryngeal 498 40.0 34.6 45.5
Oral 1,157 26.6 19.8 33.3
Oropharyngeal 894 41.3 31.8 50.7
Pharyngeal 25 15.3 3.0 27.7
Tongue 113 25.7 3.4 47.9
Tonsillar 605 66.4 57.2 75.6
Waldeyer’s ring 113 32.9 12.7 53.1
All head and neck cancers 3,649 40.0 34.6 45.5
  1. aAggregate head and neck cancer prevalence estimates include one case of paranasal sinus cancer with unadjusted prevalence estimates of 100.0%; 95% CI: 60.3% to 139.7% (adjusted values to reflect prevalence estimates exceeding 100%: 60.3%; 95% CI: 20.6% to 100.0%).